A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal ...

A large trial shows aspirin does not significantly improve disease-free survival in patients with high-risk colorectal cancer.

However, Tegtmeyer said it's not necessarily time to call it quits for investigating aspirin in this setting. "This was a small study," he told MedPage Today. "The use of 200 mg of aspirin daily ...

Led by Singapore, a 12-year, international, multi-centre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer in over 1,500 patients has been completed and published in ...

ORLANDO -- Aspirin failed to cut the intensity of organ dysfunction in patients with sepsis, a placebo-controlled phase II trial from Brazil showed. For the primary endpoint -- mean change in ...

Previously it was called classic migraine Aspirin 400 mg + caffeine 32 mg Anacin ... 50 or 100 mg p.o.; can be repeated after 2 h (max 200 mg/day), 5, 10 or 20 mg intranasally; can be repeated ...

The following is a summary of “Aspirin 162 mg vs 81 mg for preeclampsia prophylaxis in high-risk obese individuals: a ...